Hélène Hovington

Université Laval — Canada

Medicine · Health Sciences

20h-index2.5kcitations102works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(51), Prostate Cancer Diagnosis and Treatment(25), Bladder and Urothelial Cancer Treatments(17), Cancer, Lipids, and Metabolism(12), Radiomics and Machine Learning in Medical Imaging(9)

Publications101 total

Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts
European Urology Oncology·2025· 2 cited
Plasma ANGPTL3, Apo CIII, leptin, and lipid levels in patients with metastatic prostate cancer.
Journal of Clinical Oncology·2025
Supplementary Table 9 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Figure 7 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 1 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 3 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 10 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Figures from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Data from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 2 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 11 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Figure 2 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Figure 3 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Figure 4 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Figure 6 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 4 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 6 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 5 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Figure 5 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
Supplementary Table 8 from The Germline and Somatic Origins of Prostate Cancer Heterogeneity
2025Open Access
page 1 of 6Next →

Frequent Co-authors

Yves Fradet(41), Louis Lacombe(31), Alain Bergeron(25), Bernard Têtu(19), Hélène LaRue(14), Hervé Brisson(12), Theodorus van der Kwast(11), Paul C. Boutros(10), Dominique Trudel(10), Michèle Orain(9), Valérie Picard(9), Robert G. Bristow(9), Chantal Guillemette(9), Michael Fraser(8), David Simonyan(8), Éric Lévesque(8), Fred Saad(8), Julie Livingstone(7), Vincent Fradet(7), Mathieu Latour(7)